Drugmaker Insys Therapeutics filed for Chapter 11 bankruptcy protection on Monday, about a week after agreeing to pay $225 million to settle a US probe into bribes it paid to doctors for prescribing a powerful opioid medication. The filing in US Bankruptcy Court in the District of Delaware made Insys the first drug manufacturer to…

Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here